NCT03725787

Brief Summary

Pressure Ulcers are a serious and common problem for residents admitted to long-term care facilities and community care patients. They represent a major burden to patients, carers and the Healthcare system, affecting approximately 1 in 20 community patients. International guidelines recommend the use of pressure redistribution support surfaces, systematic patient repositioning and preventive skin care to prevent pressure ulcers. It has been acknowledged that a significant proportion of pressure ulcers are avoidable. The prevalence of pressure ulcers is 1 of the 4 common harms recorded in the UK NHS Safety Thermometer, a local improvement tool for measuring, monitoring and analyzing patient harms across a range of settings, including nursing homes, community nursing and hospitals on a monthly basis. Static or reactive overlay mattresses are an example of a low-tech constant low-pressure support. Static air mattresses maintain a continuous low air pressure that exerts a pressure redistributing effect. Serraes and Beeckman found a pressure ulcer incidence of 5.1% in patients placed on static air support (mattress overlay, heel wedge and seat cushion) in a high risk population in a nursing home setting in Belgium. The CuroCell SAM PRO (Care of Sweden AB) is a static air mattress overlay system used as prevent and treat pressure ulcers (up to category 3) and for pain therapy. The aim of current study is to measure pressure ulcer incidence on the CuroCell Sam PRO static air mattress in nursing home residents at risk for pressure ulcer development over a 30-day period in Belgium.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2018

Typical duration for not_applicable

Geographic Reach
1 country

8 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 4, 2018

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

October 25, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 31, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 6, 2019

Completed
1.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 6, 2020

Completed
Last Updated

May 6, 2021

Status Verified

October 1, 2018

Enrollment Period

11 months

First QC Date

October 25, 2018

Last Update Submit

May 3, 2021

Conditions

Keywords

Static air support surfaceSupport deviceElderlyPrevention

Outcome Measures

Primary Outcomes (1)

  • Pressure ulcer incidence (Cat. II+), (NPUAP classification system)

    Development of at least 1 pressure ulcer Cat. II+ during study period, not associated with the use of medical devices

    30 days

Secondary Outcomes (2)

  • Incidence rate of Cat. I pressure ulcers, (NPUAP classification system)

    30 days

  • Comfort of participants (self developed questionnaire)

    30 days

Study Arms (1)

CuroCell S.A.M. ® pro mattress

EXPERIMENTAL

Mattresses of eligible participants will be replaced by a static air pressure redistribution mattress (CuroCell S.A.M. ® Pro).

Device: CuroCell S.A.M. ® pro mattress

Interventions

During 30 days, participants will use the static air mattress.

CuroCell S.A.M. ® pro mattress

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • At risk of pressure ulcer development based on a Braden score ≤ 17
  • Bedbound or chair bound
  • Aged ≥ 65

You may not qualify if:

  • Short-stay residents (expected length of stay ≤14 days)
  • End of life care
  • Medical contraindication for patient repositioning/turning
  • Pressure ulcer Cat. II+ present on initial evaluation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (8)

WZC Sint-Vincentius

Deinze, Oost-Vlaanderen, 9800, Belgium

Location

WZC Sint-Jozef

Ghent, Oost-Vlaanderen, 9000, Belgium

Location

WZC Sint-Vincentius

Kaprijke, Oost-Vlaanderen, 9970, Belgium

Location

WZC Brugse Vaart

Mariakerke, Oost-Vlaanderen, 9030, Belgium

Location

Provinciaal Zorgcentrum Lemberge

Merelbeke, Oost-Vlaanderen, 9820, Belgium

Location

WZC Onderdale

Ursel, Oost-Vlaanderen, 9910, Belgium

Location

Residentie Vroonstalle

Wondelgem, Oost-Vlaanderen, 9032, Belgium

Location

WZC Sint-Rafaël

Liedekerke, Vlaams-Brabant, 1770, Belgium

Location

Related Publications (3)

  • National Pressure Ulcer Advisory Panel, European Pressure Ulcer Advisory Panel and Pan Pacific Pressure Injury Alliance. Prevention and Treatment of Pressure Ulcers: Quick Reference Guide. Emily Haesler (Ed.). Cambridge Media: Osborne Park, Western Australia; 201.

    BACKGROUND
  • Levy A, Kopplin K; BS; Gefen A. Computer simulations of efficacy of air-cell-based cushions in protecting against reoccurrence of pressure ulcers. J Rehabil Res Dev. 2014;51(8):1297-319. doi: 10.1682/JRRD.2014.02.0048.

    PMID: 25625315BACKGROUND
  • Brown S, Smith IL, Brown JM, Hulme C, McGinnis E, Stubbs N, Nelson EA, Muir D, Rutherford C, Walker K, Henderson V, Wilson L, Gilberts R, Collier H, Fernandez C, Hartley S, Bhogal M, Coleman S, Nixon JE. Pressure RElieving Support SUrfaces: a Randomised Evaluation 2 (PRESSURE 2): study protocol for a randomised controlled trial. Trials. 2016 Dec 20;17(1):604. doi: 10.1186/s13063-016-1703-8.

    PMID: 27993145BACKGROUND

Related Links

MeSH Terms

Conditions

Pressure Ulcer

Condition Hierarchy (Ancestors)

Skin UlcerSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Dimitri Beeckman, Phd

    Study Principal Investigator

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 25, 2018

First Posted

October 31, 2018

Study Start

March 4, 2018

Primary Completion

February 6, 2019

Study Completion

October 6, 2020

Last Updated

May 6, 2021

Record last verified: 2018-10

Locations